Comment on Jankovic et al. Understanding the Benefits of CO<sub>2</sub> Laser Treatment for Vulvovaginal Atrophy. <i>Medicina</i> 2024, <i>60</i>, 1059. [PDF]
We write with concerns regarding the recent publication of "Understanding the Benefits of CO2 Laser Treatment for Vulvovaginal Atrophy" [...].
Broomfield C, Li F, Abbott J.
europepmc +4 more sources
The effectiveness of rehabilitation in vulvovaginal atrophy
Objective: to evaluate the effectiveness and safety of rehabilitation programmes in patients with vulvovaginal atrophy (VVA).Material and methods. The study involved 350 patients with VVA in surgical (n=140) and natural (n=140) menopause, the control group included 70 women without VVA.
D. М. Ampilogova +5 more
semanticscholar +4 more sources
Effectiveness of Erbium: YAG Laser in the Treatment of Vulvovaginal Atrophy in Women Who Survived Breast Cancer. [PDF]
Genitourinary syndrome of menopause (GSM) is prevalent among breast cancer survivors (BCS), often exacerbated by oncologic treatments and compounded by contraindications to hormone‐based therapies.
Ferreira KST +6 more
europepmc +2 more sources
An online survey on coping methods for genitourinary syndrome of menopause, including vulvovaginal atrophy, among Japanese women and their satisfaction levels. [PDF]
BackgroundThis study aimed to explore the current situation and existing issues regarding the management of vulvovaginal atrophy (VVA) or the genitourinary syndrome of menopause (GSM). A nationwide web-based questionnaire survey was conducted among 1,031
Ohta H +4 more
europepmc +3 more sources
Effects of vaginal estrogen on serum estradiol during aromatase inhibitor therapy in breast cancer patients with vulvovaginal atrophy: a prospective trial. [PDF]
This study aimed to analyze changes in serum estradiol (E2) levels during concurrent vaginal estradiol therapy and adjuvant letrozole in postmenopausal breast cancer (BC) patients with vulvovaginal atrophy (VVA).
Faltinová M +8 more
europepmc +2 more sources
Understanding the Benefits of CO2 Laser Treatment for Vulvovaginal Atrophy. [PDF]
Background and Objectives: Postmenopausal vaginal discomfort is often attributed to vulvovaginal atrophy (VVA). Women with VVA experience symptoms such as vaginal dryness, itching, burning, irritation, and dyspareunia.
Jankovic S +5 more
europepmc +2 more sources
Vaginal hormone-free moisturising cream is not inferior to an estriol cream for treating symptoms of vulvovaginal atrophy: Prospective, randomised study. [PDF]
This prospective, open-label, multicentre, multinational, randomised trial investigated the non-inferiority of treatment with a vaginal hormone-free moisturising cream compared to a vaginal estriol (0.1%) cream in a panel of post-menopausal women ...
Garcia de Arriba S +5 more
europepmc +3 more sources
Multifaceted Impact of CO2 Laser Therapy on Genitourinary Syndrome of Menopause, Vulvovaginal Atrophy and Sexual Function. [PDF]
Genitourinary syndrome of menopause (GSM) encompasses a range of distressing symptoms in the vulvovaginal and/or bladder–urethral regions related to menopause changes, negatively influencing woman’s quality of life and sexual activity.
Jankovic S +5 more
europepmc +2 more sources
Lubricants application in vulvovaginal atrophy [PDF]
Lubricants application in vulvovaginal atrophy Yu.E. Dobrokhotova, S.A. Khlynova Pirogov Russian National Research Medical University, Moscow, Russian Federation Interim periods as well as the postmenopausal period are extremely important in relation to the development of the disease and the complications associated with estrogen deficiency. Although
Yu.E. Dobrokhotova, S.A. Khlynova
openaire +2 more sources
Comparison of the effects of vaginal royal jelly and vaginal estrogen on quality of life, sexual and urinary function in postmenopausal women [PDF]
Introduction: Several causes can disturb the quality of life in postmenopausal women. Stress, urinary incontinence is one of the factors that can influence the quality of life of women, since they evade social activities and limit their behavior ...
Miraj, S., Rafiean, M., Seyyedi, F.
core +3 more sources

